0000950170-23-013531.txt : 20230419 0000950170-23-013531.hdr.sgml : 20230419 20230419173305 ACCESSION NUMBER: 0000950170-23-013531 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230417 FILED AS OF DATE: 20230419 DATE AS OF CHANGE: 20230419 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Blanchfield Paul CENTRAL INDEX KEY: 0001801395 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36569 FILM NUMBER: 23830881 MAIL ADDRESS: STREET 1: C/O LANTHEUS HOLDINGS, INC. STREET 2: 331 CITY: NORTH BILLERICA STATE: MA ZIP: 01862 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lantheus Holdings, Inc. CENTRAL INDEX KEY: 0001521036 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 352318913 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 331 TREBLE COVE ROAD CITY: NORTH BILLERICA STATE: MA ZIP: 01862 BUSINESS PHONE: 978 671-8001 MAIL ADDRESS: STREET 1: 331 TREBLE COVE ROAD CITY: NORTH BILLERICA STATE: MA ZIP: 01862 FORMER COMPANY: FORMER CONFORMED NAME: Lantheus MI Holdings, Inc. DATE OF NAME CHANGE: 20110517 4 1 ownership.xml 4 X0407 4 2023-04-17 0001521036 Lantheus Holdings, Inc. LNTH 0001801395 Blanchfield Paul C/O LANTHEUS HOLDINGS, INC. 201 BURLINGTON ROAD, SOUTH BUILDING BEDFORD MA 01730 false true false false See Remarks false Common Stock 2023-04-17 4 A false 8464 0 A 95028 D Stock Option (right to buy) 89.16 2023-04-17 4 A false 5025 0 A 2033-04-16 Common Stock 5025 5025 D Consists of 2,821 restricted stock units that vest in equal installments over a three-year period and 5,643 Total Shareholder Return performance-based restricted stock units ("PSUs") that cliff vest following a three-year performance period. The amount of PSUs included in this Report reflects the target award, however the ultimate award size can range from 0% to 200% of the target based on the actual performance achieved at the end of the performance period. Includes 221 shares acquired under the LNTH employee stock purchase plan on March 13, 2023. The option vests in three equal annual installments beginning on April 17, 2024. President /s/ Daniel M. Niedzwiecki, attorney-in-fact 2023-04-19